Kate Wooldrage

3.8k total citations · 1 hit paper
40 papers, 2.5k citations indexed

About

Kate Wooldrage is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Kate Wooldrage has authored 40 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Kate Wooldrage's work include Colorectal Cancer Screening and Detection (32 papers), Gastric Cancer Management and Outcomes (22 papers) and Colorectal Cancer Surgical Treatments (13 papers). Kate Wooldrage is often cited by papers focused on Colorectal Cancer Screening and Detection (32 papers), Gastric Cancer Management and Outcomes (22 papers) and Colorectal Cancer Surgical Treatments (13 papers). Kate Wooldrage collaborates with scholars based in United Kingdom, United States and Canada. Kate Wooldrage's co-authors include Wendy Atkin, Ines Kralj‐Hans, Stephen W. Duffy, Jane Wardle, Rob Edwards, John Northover, D. Max Parkin, Andrew Hart, Jack Cuzick and Amanda J. Cross and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Kate Wooldrage

38 papers receiving 2.4k citations

Hit Papers

Once-only flexible sigmoidoscopy screening in prevention ... 2010 2026 2015 2020 2010 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate Wooldrage United Kingdom 20 2.0k 1.4k 774 596 188 40 2.5k
Øyvind Holme Norway 20 2.0k 1.0× 1.4k 1.0× 550 0.7× 664 1.1× 201 1.1× 71 2.5k
Antonio Z. Gimeno‐García Spain 25 1.7k 0.8× 1.3k 0.9× 427 0.6× 750 1.3× 174 0.9× 93 2.2k
Grazia Grazzini Italy 26 1.7k 0.9× 963 0.7× 621 0.8× 499 0.8× 472 2.5× 85 2.1k
Beth G. McFarland United States 4 2.2k 1.1× 1.3k 0.9× 849 1.1× 525 0.9× 124 0.7× 4 2.5k
Stephen P Halloran United Kingdom 19 1.4k 0.7× 673 0.5× 380 0.5× 446 0.7× 188 1.0× 42 1.6k
Rob Edwards United Kingdom 10 1.9k 1.0× 1.0k 0.7× 652 0.8× 433 0.7× 130 0.7× 12 2.5k
S N Glick United States 11 2.3k 1.1× 1.3k 0.9× 1.0k 1.3× 632 1.1× 155 0.8× 20 2.8k
Manya Charette Canada 20 1.7k 0.8× 605 0.4× 613 0.8× 546 0.9× 62 0.3× 43 2.5k
T.W. Balfour United Kingdom 18 2.7k 1.4× 1.8k 1.3× 1.2k 1.6× 1.0k 1.7× 202 1.1× 39 3.4k
Seth N. Glick United States 9 2.8k 1.4× 1.7k 1.2× 970 1.3× 775 1.3× 155 0.8× 19 3.2k

Countries citing papers authored by Kate Wooldrage

Since Specialization
Citations

This map shows the geographic impact of Kate Wooldrage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Wooldrage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Wooldrage more than expected).

Fields of papers citing papers by Kate Wooldrage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Wooldrage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Wooldrage. The network helps show where Kate Wooldrage may publish in the future.

Co-authorship network of co-authors of Kate Wooldrage

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Wooldrage. A scholar is included among the top collaborators of Kate Wooldrage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Wooldrage. Kate Wooldrage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Juul, Frederik Emil, Amanda J. Cross, Robert E. Schoen, et al.. (2024). Effectiveness of Colonoscopy Screening vs Sigmoidoscopy Screening in Colorectal Cancer. JAMA Network Open. 7(2). e240007–e240007. 14 indexed citations
4.
Juul, Frederik Emil, Amanda J. Cross, Robert E. Schoen, et al.. (2022). 15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality. Annals of Internal Medicine. 175(11). 1525–1533. 27 indexed citations
5.
Cross, Amanda J., Kevin Pack, Matthew D. Rutter, et al.. (2022). Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study. Health Technology Assessment. 26(26). 1–156. 7 indexed citations
6.
Harewood, Rhea, et al.. (2022). Adenoma characteristics associated with post-polypectomy proximal colon cancer incidence: a retrospective cohort study. British Journal of Cancer. 126(12). 1744–1754. 8 indexed citations
7.
Wooldrage, Kate, et al.. (2020). Is surveillance colonoscopy necessary for all patients with bowel polyps?. BMJ. 369. m1706–m1706. 4 indexed citations
8.
Bright, Chloe J., et al.. (2020). Errors in determination of net survival: cause-specific and relative survival settings. British Journal of Cancer. 122(7). 1094–1101. 19 indexed citations
9.
Pinsky, Paul F., Magnus Løberg, Carlo Senore, et al.. (2018). Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening. Gastroenterology. 155(4). 1059–1068.e2. 8 indexed citations
10.
Cross, Amanda J., Kate Wooldrage, Ines Kralj‐Hans, et al.. (2018). Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study. Gut. 68(9). 1642–1652. 52 indexed citations
11.
Cross, Amanda J., Kate Wooldrage, Kevin Pack, et al.. (2018). Whole-colon investigation vs. flexible sigmoidoscopy for suspected colorectal cancer based on presenting symptoms and signs: a multicentre cohort study. British Journal of Cancer. 120(2). 154–164. 12 indexed citations
12.
Atkin, Wendy, Kate Wooldrage, Donald Maxwell Parkin, et al.. (2017). Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. The Lancet. 389(10076). 1299–1311. 223 indexed citations
13.
Atkin, Wendy, Kate Wooldrage, Amy Brenner, et al.. (2017). Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study. The Lancet Oncology. 18(6). 823–834. 155 indexed citations
14.
Halligan, Steve, Kate Wooldrage, Edward Dadswell, et al.. (2013). Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial. The Lancet. 381(9873). 1185–1193. 114 indexed citations
15.
Langlois-Klassen, Deanne, Kate Wooldrage, Jure Manfreda, et al.. (2011). Piecing the puzzle together: foreign-born tuberculosis in an immigrant-receiving country. European Respiratory Journal. 38(4). 895–902. 28 indexed citations
16.
Atkin, Wendy, Rob Edwards, Ines Kralj‐Hans, et al.. (2010). Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. The Lancet. 375(9726). 1624–1633. 1159 indexed citations breakdown →
17.
Hegele, Richard G., Jure Manfreda, Kate Wooldrage, et al.. (2007). Relationship of early childhood viral exposures to respiratory symptoms, onset of possible asthma and atopy in high risk children: The Canadian asthma primary prevention study. Pediatric Pulmonology. 42(3). 290–297. 47 indexed citations
19.
Wooldrage, Kate, et al.. (2006). Introduction of Leukotriene Receptor Antagonists in Manitoba. Canadian Respiratory Journal. 13(2). 94–98. 1 indexed citations
20.
Tyas, Suzanne L., Robert B. Tate, Kate Wooldrage, Jure Manfreda, & Laurel A. Strain. (2005). Estimating the Incidence of Dementia: The Impact of Adjusting for Subject Attrition Using Health Care Utilization Data. Annals of Epidemiology. 16(6). 477–484. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026